Article citationsMore>>
Seth, P., Lunetta, K.L., Bell, D.W., Gray, H., Nasser, S.M., Rhei, E., Kaelin, C.M., Iglehart, D.J., Marks, J.R., Garber, J.E., Haber, D.A. and Polyak, K. (2000) Phenol sulfotransferases: Hormonal regulation, polymorphism, and age of onset of breast cancer. Cancer Research, 60, 6859-6863.
has been cited by the following article:
-
TITLE:
More Stable, More Estrogenic: The SERM-ERα LBD Complex
AUTHORS:
Li Gao, Yaoquan Tu, Leif A. Eriksson
KEYWORDS:
Breast Cancer; Tamoxifen Resistance; Molecular Dynamics Simulations;
Dihydrobenzoxathiin; SERM
JOURNAL NAME:
Journal of Biophysical Chemistry,
Vol.2 No.3,
August
9,
2011
ABSTRACT: Many synthetic selective estrogen receptor modulators (SERMs) have been cocrystallized with the human estrogen receptor α ligand binding domain (ERα LBD). Despite stabilizing the same canonical inactive conformation of the LBD, most SERMs display different ligand-dependent pharmacological profiles. We show here that increased partial agonism of SERMs is associated with increased conformational stability of the SERM-LBD complexes, by investigation of dihydrobenzoxathiin-based SERMs using molecular modelling techniques. Analyses of tamoxifen (TAM) and 4-hydroxytamoxifen (OHT) in complex with the LBD furthermore indicates that the conversion of TAM to OHT increases both the affinity to ERα and the partial agonism of the anti-cancer drug, which provides a plausible explanation of the counterintuitive results of TAM therapy.
Related Articles:
-
Abdelbaset Mohamed Elasbali, Elyasa Mustafa Elfakia Mohammed, Ziad Alonzi, Rania Abdeen Hussain Abdalla, Azizah Mazi Aldaham, Diem Fayez Aljubab, Naif Muflih Alsharari, Hussain Gadelkarim Ahmed
-
Karen G. Kearney, Richard E. Hicks
-
Mouna Zerradi, François Houle, Jacques Huot
-
Paul H. Levine, Heather J. Hoffman, Audra MacNeil, Salman Hashmi, Sherry X. Yang, Stephen Hewitt, Kenneth L. van Golen, Sandra M. Swain
-
Fatima Zahra Laamiri, Abdellatif Bouayad, Nadia Hasswane, Samir Ahid, Mustapha Mrabet, Barkat Amina